Protalix BioTherapeutics Inc (PLX) Has A Promising Outlook For 2025

Protalix BioTherapeutics Inc (AMEX:PLX) has a beta value of -0.04 and has seen 1.74 million shares traded in the recent trading session. The company, currently valued at $129.62M, closed the recent trade at $1.63 per share which meant it lost -$0.09 on the day or -5.23% during that session. The PLX stock price is -90.18% off its 52-week high price of $3.10 and 49.69% above the 52-week low of $0.82.

Protalix BioTherapeutics Inc (AMEX:PLX) trade information

Sporting -5.23% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the PLX stock price touched $1.63 or saw a rise of 44.37%. Year-to-date, Protalix BioTherapeutics Inc shares have moved -13.30%, while the 5-day performance has seen it change -42.61%. Over the past 30 days, the shares of Protalix BioTherapeutics Inc (AMEX:PLX) have changed -29.44%.

Protalix BioTherapeutics Inc (PLX) estimates and forecasts

The company’s shares have gained 33.61% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 63.34%.

1 analysts offering their estimates for the company have set an average revenue estimate of 21.6M for the current quarter. 1 have an estimated revenue figure of 23.1M for the next ending quarter. Year-ago sales stood 3.68M and 13.3M respectively for this quarter and the next, and analysts expect sales will grow by 487.44% for the current quarter and 63.34% for the next.

PLX Dividends

Protalix BioTherapeutics Inc is expected to release its next earnings report in June this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Protalix BioTherapeutics Inc (AMEX:PLX)’s Major holders

The top two institutional holders are MILLENNIUM MANAGEMENT LLC with over 0.81 million shares worth more than $0.95 million. As of 2024-06-30, MILLENNIUM MANAGEMENT LLC held 1.1106% of shares outstanding.

The other major institutional holder is RENAISSANCE TECHNOLOGIES LLC, with the holding of over 0.8 million shares as of 2024-06-30. The firm’s total holdings are worth over $0.94 million and represent 1.1016% of shares outstanding.

Also the top two Mutual Funds that are holding company’s shares are Unified Series Trust-AUER GROWTH FUND and Bridgeway Funds, Inc.-Ultra-Small Company Market Fund . As of Mar 31, 2025 , the former fund manager holds about 0.25% shares in the company for having 200.0 shares of worth $0.33 million while later fund manager owns 180.0 shares of worth $0.29 million as of Dec 31, 2024 , which makes it owner of about 0.23% of company’s outstanding stock.